Safety and Efficacy of RAD001 (Everolimus) Monotherapy Plus Best Supportive Care in Patients With Advanced Gastric Cancer (AGC)
Clinical trial NCT00879333 · COMPLETED
Trial details
- NCT number
- NCT00879333
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2014-01-01
- Enrollment
- 656
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.